I
Power Law company profile
Invivyd
Biotech & Life Sciences · Waltham, United States · Founded 2020 · IPO 2021 Unicorn
Valuation
$1.80B
Market cap · 2026
Revenue
$25M
Latest reported FY
Global footprint
Where Invivyd has talent and traffic
Web traffic by country
17K
monthly visits
across markets
across markets
🇺🇸 United States58.8%
🇬🇧 United Kingdom39.4%
🇳🇱 Netherlands2.9%
Patent intelligence
$2M patent portfolio · 5 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$2M
0.10% of market cap · 43.4× smaller than top peer Arcus Biosciences ($74M)
5 active patent families
Where Invivyd innovates
DiseaseConformational epitopeS AntibodyAntigen Binding FragmentVirology
Below peer median on Legal, Strategic, Market
Quality vs same-sector peers
Invivyd on the five Patsnap quality dimensions
Invivyd in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Invivyd concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Invivyd and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Invivyd on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.